| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |